Detalhe da pesquisa
1.
Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care.
Neurol Sci
; 45(4): 1589-1597, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919441
2.
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.
Ann Neurol
; 91(4): 483-495, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150168
3.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171104
4.
Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotype.
Eur J Neurol
; 30(9): 2736-2744, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294976
5.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Brain
; 145(8): 2796-2805, 2022 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325059
6.
Alteration of the translational readthrough isoform AQP4ex induces redistribution and downregulation of AQP4 in human glioblastoma.
Cell Mol Life Sci
; 79(3): 140, 2022 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187599
7.
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Neurol Sci
; 44(11): 4001-4011, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311951
8.
Interrogating large multiple sclerosis registries and databases: what information can be gained?
Curr Opin Neurol
; 35(3): 271-277, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674068
9.
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Rheumatology (Oxford)
; 61(8): 3448-3460, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864921
10.
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Ann Neurol
; 89(4): 780-789, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33480077
11.
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
Mult Scler
; 28(14): 2177-2189, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000489
12.
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Mult Scler
; 28(7): 1034-1040, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34328824
13.
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening.
Mult Scler
; 28(3): 472-479, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132146
14.
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.
Mult Scler
; 28(13): 2137-2141, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296189
15.
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
Mult Scler
; 28(14): 2243-2252, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971322
16.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Mult Scler
; 28(9): 1424-1456, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196927
17.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Eur J Neurol
; 29(12): 3728-3736, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36086905
18.
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.
Eur J Neurol
; 29(2): 535-542, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735749
19.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
20.
On epilepsy perception: Unravelling gaps and issues.
Epilepsy Behav
; 137(Pt A): 108952, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306590